The dose distributions within the real volumes of tumor targets and critical organs during internal target volume-based intensity-modulated radiation therapy (ITV-IMRT) for liver cancer were recalculated by applying the effects of actual respiratory organ motion, and the dosimetric features were analyzed through comparison with gating IMRT (Gate-IMRT) plan results. The ITV was created using MIM software, and a moving phantom was used to simulate respiratory motion. The doses were recalculated with a 3 dose-volume histogram (3DVH) program based on the per-field data measured with a MapCHECK2 2-dimensional diode detector array. Although a sufficient prescription dose covered the PTV during ITV-IMRT delivery, the dose homogeneity in the PTV was inferior to that with the Gate-IMRT plan. We confirmed that there were higher doses to the organs-at-risk (OARs) with ITV-IMRT, as expected when using an enlarged field, but the increased dose to the spinal cord was not significant and the increased doses to the liver and kidney could be considered as minor when the reinforced constraints were applied during IMRT plan optimization. Because the Gate-IMRT method also has disadvantages such as unsuspected dosimetric variations when applying the gating system and an increased treatment time, it is better to perform a prior analysis of the patient's respiratory condition and the importance and fulfillment of the IMRT plan dose constraints in order to select an optimal IMRT method with which to correct the respiratory organ motional effect.
Introduction
Intensity-modulated radiation therapy (IMRT) has been used effectively in complicated clinical cases that require improved dose distribution to tumor targets and reduced doses to normal tissues and critical organs near the tumor.
Although IMRT has been most often performed in cases of head and neck and prostate cancer in which the tumor motion is very small and within a limited range, this technique has also been applied to tumors located in the abdomen and chest, including liver cancer and lung cancer which are affected by respiratory organ motion. Many studies on dosimetric errors during IMRT beam delivery consequent to respiratory organ motion have been conducted, and some practical methods have been devised to resolve these errors. [1] [2] [3] [4] [5] [6] [7] [8] An active breathing coordinator (ABC) system and real-time position management (RPM) respiratory gating system are typically applied to clinical cases in order to reduce the respiratory organ motional effects. These methods often require the patient's cooperation with controlling their regulatory respiration pattern, and the motional correlation between the external marker and internal organ should be uniform in the RPM gating system. These requirements are very difficult to achieve in actual clinical practice, which can introduce more errors in cases involving IMRT, given the complicated dose distributions delivered through the accurate movements of a multi-leaf collimator (MLC). IMRT administered through sliding window-type MLC movements can lead to substantial errors in the gating method due to the possible dosimetric inconstancy and inaccuracy of the MLC position during the repeated-beam on-off process. 9) Another conventional way to consider the organ motional effect without using a beam on-off gating system is to apply the entire range of respiratory organ motion as a margin when delineating the planning target volume (PTV). The accurate motion range can be applied to the internal target volume (ITV) using 4-dimensional computed tomography (4DCT), which can minimize unnecessary margins when delineating the PTV. [10] [11] [12] [13] When creating an IMRT plan based on the 4DCT-contoured ITV, there is no need to apply the gating method and stable IMRT can be performed without dosimetric error, due to the beam on-off process. However, a disadvantage of the ITV method is that the dose to the organ at risk (OAR) near the PTV might be increased as a result of the treatment field, which is larger than that used in the gating method. It is also difficult to analyze the accurate dosimetric distributions in the real PTV and OARs using ITV because the IMRT plan is created using an inflated PTV and OARs, which differ from the actual volumes.
In this study, we devised a method for calculating the dose distributions in the real PTV and OARs when an ITV-based IMRT (ITV-IMRT) plan was delivered under the condition of actual respiratory organ motion, and analyzed the calculated dosimetric data through comparison with a gating IMRT (Gate-IMRT) plan. The ITV-IMRT plans for this study were created from 4DCT scans of liver cancer patients, and an accurate ITV that applied the entire motion range was delineated.
The doses in the patients' CT data were recalculated based on the measured ITV-IMRT doses delivered under the condition of respiratory motion in each patient. The calculated dose distributions in the actual volumes of the PTV and OARs were compared with the results of the Gate-IMRT plan and analyzed for the application of the proper IMRT method for treating liver tumors, which includes a variable motional aspect due to the differences in the patients' respiratory conditions.
Materials and Methods
The 4DCT data for 10 patients who had been treated with Gate-IMRT for liver cancer were selected to create ITV-IMRT plans. The 4DCT data were acquired with a BrightSpeed CT scanner (GE Medical Systems, Milwaukee, WI), and retrospectively reconstructed 10-phase CT data were transferred to the MIM program (MIM Software Inc., Cleveland, OH) to generate the ITV and planning OAR volume (PRV). The CTV and OAR contours in 50%-phase CT for the Gate-IMRT plan were propagated to the other phase CT using a deformable registration algorithm, and all contours from each phase CT were combined into a final ITV and PRVs.
The PTV was generated by adding a 0.5-cm setup margin to the ITV, and all ITV-IMRT plans were made using 7 fixed Gy, applied in 25 fractions, and the optimization constraints for the PTV were that the 95% isodose (prescription) surface had to cover 95% of the PTV and that no portion of the PTV could receive more than 110% of the prescription dose. The
OARs considered during the optimization were the liver, kidney, and spinal cord. The liver constraint was that the volume irradiated with ＞30 Gy should comprise ＜30% of the total volume. The kidney constraint was that the volume irradiated with ＞20 Gy should comprise ＜20% of the total volume.
The dose limit to the spinal cord was 45 Gy.
The Dynamic Platform Model 008PL (CIRS Inc., Norfolk, VA), which can simulate respiratory motion, was used to apply the same respiratory motional effects in each patient during ITV-IMRT beam delivery. The period and range of respiratory motion in the region of tumor were measured in all patients from 4DCT-generated movie data, and the same period and range were applied when operating the dynamic phantom to realize coincident respiratory conditions in each patient. In this study, single motional range in the superior-inferior direc- 
Results
An example of ITV delineation with the MIM program is shown in Fig. 3 , and proper contour expansion can be verified Gy, (95% of the prescribed dose) was 0.66±4.85%. Fig. 7 shows the dose homogeneity within a PTV, which was calculated as a homogeneity index (HI) using equation (1). 14) The average HI of the PTV during ITV-IMRT delivery was 13.66± 9.32% which was slightly inferior to the average HI value of, 10.10±6.98%, for the Gate-IMRT plan.
HI = (D2%−D98%) ×100% (1) (Dprescription)

D2%: the dose to the 2% of the target volume, as displayed on the DVH D98%: the dose to the 98% of the volume as displayed on the cumulative DVH Dprescription: the prescription dose
The results of a comparison of the OAR DVH differences are shown in Fig. 8, 9 , and 10. Fig. 8 shows the results of a liver comparison, in which a higher dose was irradiated during ITV-IMRT delivery than with the Gate-IMRT plan. The average dose increases were 2.93±1.80 Gy for the Dmax, 2.47±1. 16 Gy for the Dmean, and 2.31±1.66 Gy for the dose to 30% of the liver volume on the cumulative DVH (D30%). Higher irradiation doses were also delivered to the spinal cord during ITV-IMRT delivery, as shown in Fig. 10 ; the average dose increases were 1.22±1.32 Gy for the Dmax and 1.44±0.84
Gy for the Dmean. 
Discussion
The PTV and OARs have virtually enlarged volumes that differ from those of real tumors and organs when the entire motional range is considered during ITV-IMRT planning. This
phenomenon makes it difficult to analyze the exact dose distributions in the actual PTV and OARs, although increased doses to the OARs can be assumed with ITV-IMRT, given the enlarged field size. In this study, the real dose distributions in we were able to confirm that higher actual doses were delivered to the PTV and OARs that moved within the enlarged field area.
The correlation between the volume increases of the OARs and the respiratory motional range was negative, which might have been a result of the selection of a motional range in the area of the PTV's center that was not in the region of OARs.
Although the exact 3-dimensional movements of the organs could not be simulated in this study, the motional effect could be evaluated sufficiently well by applying the largest motional change in the superior-inferior direction.
In this study, the accuracy of the dosimetric data calculated with the 3DVH program could be considered reliable because the dose calculation algorithm that incorporates the per-field dose measurement data using 3DVH has already been verified in many studies. 15, 16) The average increase in the Dmean of the PTV was 1.30±
0.96 Gy, and the Dmax and V95% of the PTV were also slightly elevated with ITV-IMRT delivery. Although the sufficient prescription dose coverage of the PTV could be considered a benefit of ITV-IMRT, the dose homogeneity in the PTV, evaluated using the HI, was inferior to that of the Gate-IMRT plan. This double-sided nature of the dose distribution to the PTV should be considered in ITV-IMRT cases.
Although the potential disadvantage of ITV-IMRT with respect to higher dose distribution to the OARs was again confirmed in this study, the dose increase rate was modest compared with the constraint criteria, and these increases should be evaluated from a biological point of view, rather than simply from a numerical dose increase. In other words, the dose increases should be analyzed with regard to the impact on the increased probability of complications in the OARs. 
Conclusions
Dose distributions within the real volumes of the PTV and OARs during ITV-IMRT for liver cancer while under respiratory motional conditions could be acquired, and these data confirmed that higher irradiation doses were delivered to the OARs when compared to those calculated in the Gate-IMRT plan. However, the increased doses could be considered as minor risk factors if constraints were reinforced during the IMRT optimization process. Because Gate-IMRT cannot always be considered an ideal method with which to correct the respiratory motional effect, given the dosimetric variations in the gating system application and the increased treatment time, a prior analysis for optimal IMRT method selection should be performed while considering the patient's respiratory condition and IMRT plan results.
